Tonix Pharmaceuticals joins Russell 3000 and 2000 indexes, expanding institutional visibility

Proactive - Interviews for investors

Tonix Pharmaceuticals Holdings CEO Dr Seth Lederman joined Steve Darling from Proactive to announce a significant milestone for the company—its inclusion in the Russell 3000® Index, with automatic membership in the Russell 2000® Index, effective immediately. This development enhances Tonix’s visibility and credibility among institutional investors and fund managers worldwide. The inclusion follows the annual reconstitution of the Russell U.S. indexes, which captures the 4,000 largest U.S.-based stocks as of April 30, ranked by total market capitalization. FTSE Russell, the global index provider, determines inclusion using objective, rules-based criteria, primarily market cap rankings and style attributes. The Russell 3000® Index represents approximately 98% of the investable U.S. equity market, while the Russell 2000® Index, a subset, tracks the small-cap segment and is a benchmark for asset managers and mutual funds focused on emerging and growth-oriented companies. According to FTSE Russell, as of the end of June 2024, an estimated $10.6 trillion in assets are benchmarked against the suite of Russell U.S. indexes. Inclusion in these indexes often results in increased institutional ownership, higher trading volumes, and broader market recognition for listed companies. Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, is focused on developing innovative therapeutics across central nervous system disorders, rare diseases, immunology, and infectious diseases. This index inclusion comes at a pivotal moment, as the company continues to advance its pipeline and expand its presence in both scientific and investment communities. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp ##Russell3000 #BiotechInvesting #MPOXVaccine #Smallpox #TNX801 #VaccineDevelopment #ClinicalTrials #PharmaceuticalNews #MedicalResearch #WHO #GlobalHealth #InfectiousDiseases #Biopharma #ProactiveInvestors